This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting neurological disorders, particularly those involving dopamine regulation. Its structural features make it valuable in creating enantiomerically pure compounds, which are essential for ensuring the efficacy and safety of chiral drugs. Additionally, it is employed in research settings to explore novel therapeutic agents and to study biochemical pathways related to morpholine derivatives. Its application extends to the development of potential treatments for conditions such as Parkinson's disease and other neurodegenerative disorders.